Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease
Laya Hooshmand Gharabagh, Ali Shargh, Mohammad Reza Mohammad Hoseini Azar, Ayda Esmaeili
Topics & Concepts
MedicineEmpagliflozinPioglitazoneMetforminNonalcoholic fatty liver diseaseType 2 diabetesInternal medicineDiseaseDiabetes mellitusFatty liverGastroenterologyEndocrinologyLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management